EssilorLuxottica: SightGlass Vision Joint Venture Begins Operation
March 17 2022 - 4:20PM
EssilorLuxottica: SightGlass Vision Joint Venture Begins Operation
SightGlass Vision Joint
Venture Begins
Operation
EssilorLuxottica and CooperCompanies
initiativeaccelerates commercialization of innovative myopia
management technologies
Charenton-le-Pont,
France and San Ramon, California
(March
17, 2022) –
EssilorLuxottica and CooperCompanies are pleased to announce the
finalization of their joint venture agreement for SightGlass
Vision. This collaboration of two global vision care leaders
accelerates the commercialization of novel spectacle lens
technologies to expand the myopia management category. SightGlass
Vision’s Diffusion Optics Technology™ incorporates thousands of
micro-dots into the lens that softly scatter light to reduce
contrast on the retina, which is intended to reduce myopia
progression in children.1
“As a global leader with a 30-year track record
in myopia research, we have been developing the myopia management
category for more than a decade. As such, we are thrilled to see
our joint venture with CooperCompanies come to life as SightGlass
Vision begins to operate and the first products start to reach the
market. Together with eye care professionals, we will be able to
grow awareness about existing solutions and improve access to
technologies that can help children today and in their future
lives,” said Norbert Gorny, co-Chief Operating Officer at
EssilorLuxottica.
“We are excited to begin this joint venture with
EssilorLuxottica to grow the overall myopia management category.
Adding spectacle lenses with SightGlass Vision technology to our
portfolio of myopia management products translates into better
eyesight and brighter lives for countless children. SightGlass
Vision’s commitment to clinically based performance fits well with
CooperVision, which has conducted the world’s longest-running
myopia management clinical study and is committed to establishing
myopia management as a standard of care for affected children,”
said Dan McBride, Chief Operating Officer and General Counsel at
CooperCompanies.
The last several decades have seen a steady rise
in the prevalence of myopia worldwide, notably under the effect of
lifestyle changes. Today affecting 2.6 billion people globally, it
is estimated that nearly 5 billion people – half the world’s
population – will be myopic by 2050.2 Myopia is the leading cause
of visual impairment in children and, over time, may contribute to
an increased risk of developing permanent vision impairment,
including macular degeneration, retinal detachment, cataract and
glaucoma, and blindness associated with high myopia.3
Notes1
Spectacles with SightGlass Vision Diffusion Optics Technology™ are
not approved for sale within the United States.2
Holden et al. Global Prevalence of myopia and high myopia and
temporal trends from 2000 through 2050. Ophthalmology 2016.
123(5):1036-423 Tideman JW et al. Association of
axial length with risk of uncorrectable visual impairment for
Europeans with myopia. JAMA Ophthalmol. 2016;134:1355-1363
- DOWNLOAD PDF VERSION OF THE NEWS RELEASE
Essilorluxottica (BIT:1EL)
Historical Stock Chart
From Apr 2024 to May 2024
Essilorluxottica (BIT:1EL)
Historical Stock Chart
From May 2023 to May 2024